Dr. Eugenia Oviedo-Joekes obtained her degree in clinical psychology at the University of Cordoba (Argentina), a PhD in social psychology and behavioural sciences methodology in Spain, and post-doctoral studies at the Andalusian School of Public Health. She is an associate professor at the School of Population and Public Health at the University of British Columbia, a research scientist in the Centre for Health Outcomes Evaluation at Providence Health Care, a Michael Smith Foundation for Health Research Scholar and a CIHR New Investigator. Her main research area is public health and addictions, with a focus on testing alternative approaches to expand and diversify treatments for vulnerable populations.
She is currently part of several Canadian Institutes of Health Research funded grants; co-investigator of North America’s first heroin-assisted treatment trial (NAOMI); and principal investigator of SALOME, a randomized clinical trial testing innovative treatments for severe, long term opioid dependency. She is also the principal investigator of the GeMa (Gender Matters) study, which evaluates gender patterns of drug use, access to care and health among long-term opioid users; and a co-investigator of the Cedar Project, a cohort of young Aboriginal people using drugs.
Most of Dr. Oviedo-Joekes publications are listed in PubMed and ResearchGate: